Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

The intersection of drug use discrimination and racial discrimination in the management of chronic non-cancer pain in United States primary care safety-net clinics: Implications for healthcare system and clinic-level changes

We report on perceptions of discrimination from the perspectives of patients with chronic non-cancer pain (CNCP) and a history of substance use and their clinicians within the structural landscape

Original research | 2023

Chronic pain, Equity, About prescribers

Accidental Drug Poisoning Crisis Community of Practice - Past Event Recordings

Archived webinar | 2023

Overdose, Harm reduction, Advocacy

Drug Policy Facts

Webpage | 2023

Policy/Regulatory

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021

To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time.

Original research | 2023

Youth, Mortality, Substitution/OAT, About PWUD, Outcomes

Examining Increasing Racial Inequities in Opioid Overdose Deaths: a Spatiotemporal Analysis of Black and White Decedents in St. Louis, Missouri, 2011–2021

The current study examines the differential geography of opioid overdose death (OOD) by race and time (i.e., pre-fentanyl versus fentanyl era) in St. Louis, Missouri.

Original research | 2023

Overdose, Mortality, Equity, About PWUD

Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders

The aims of the study are to review the current research on the association between access to medications for opioid use disorders (MOUD) and race, to identify gaps in research methods, and to prop

Lit review | 2023

Substitution/OAT, Equity

No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment – results from a natural experiment of policy change in Sweden

The present study examines the longitudinal effects of a regional patient choice reform which substantially increased availability to opioid maintenance treatment in one Swedish county, starting fr

Original research | 2023

Mortality, Policy/Regulatory, Substitution/OAT

Stigma towards Persons who Use Methamphetamine: Results from a Nationally Representative Survey of U.S. Adults

This study seeks to understand the general adult population’s knowledge, attitudes, and stigma towards methamphetamine use and people with a history of methamphetamine use.

Original research | 2023

Stigma, Stimulants, Equity

Flawed reports can harm: the case of supervised consumption services in Alberta

Commentary | 2023

SCS/OPS, Policy/Regulatory

The Psychedelic Social Club: a regulatory concept for people who use psychedelics?

Commentary | 2023

Hallucinogens/psychedelics, Policy/Regulatory

Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study

We aimed to assess the effect of methadone on non-opioid substance use compared to buprenorphine/naloxone (BUP/NX), to explore whether non-opioid substance use is associated with opioid use and ret

Original research | 2023

Substitution/OAT

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices in North America: a Retrospective Study

Assess the preliminary impact of Brave Technology Co-op’s overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North

Original research | 2023

Digital health, Overdose

Overdose and Mortality Risk following a Non-Fatal Opioid Overdose Treated by Emergency Medical Services in King County, Washington

We conducted a retrospective cohort study of EMS patients who survived a prior opioid overdose in 2019-2021 in King County, Washington.

Original research | 2023

Overdose, Mortality, About PWUD

Canadian Civil Society Advancing Safe Supply Working Group “Innovating Beyond Exclusively Medicalized Approaches”: Policy Brief and Recommendations

Report | 2023

Policy/Regulatory, Safer supply, Advocacy

Directives opérationnelles nationales sur la mise en œuvre de sites de consommation supervisée

Manuel | 2023

site de consommation supervisée / centre de prévention des surdoses, la politique / le cadre de réglementation, les drogues illégales

National Operational Guidance for the Implementation of Supervised Consumption Services

Guide or handbook | 2023

SCS/OPS, Policy/Regulatory, Illegal drugs

Implementation and evaluation of a two-eyed seeing approach using traditional healing and seeking safety in an indigenous residential treatment program in Northern Ontario

We evaluated the effectiveness of a Two-Eyed Seeing approach in a four-week harm reduction residential treatment programme for clients with a history of substance use disorder (SUD) and intergenera

Original research | 2023

Harm reduction, Wrap-around services, About PWUD, Indigenous

Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail

We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to medications to treat opioid use disorder (MOUD, ie, buprenorphine, met

Original research | 2023

Legal system/law enforcement, Substitution/OAT